NEUROENDOCRINE CARCINOMA OF THE BLADDER

Clinical trials for NEUROENDOCRINE CARCINOMA OF THE BLADDER explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMA OF THE BLADDER trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested to shrink rare, aggressive bladder cancer before surgery

Disease control Recruiting now

This study is testing whether a combination of three drugs (adebrelimab, etoposide, and cisplatin) given before bladder removal surgery can help shrink or eliminate a rare and aggressive form of bladder cancer called neuroendocrine carcinoma. About 22 patients with this specific …

Matched conditions: NEUROENDOCRINE CARCINOMA OF THE BLADDER

Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control

Last updated Mar 03, 2026 14:06 UTC

NEUROENDOCRINE CARCINOMA OF THE BLADDER

Get alerted when new NEUROENDOCRINE CARCINOMA OF THE BLADDER trials appear

New drug combo tested to shrink rare, aggressive bladder cancer before surgery